Clinical Trials Browser

Phase 2 × Hematopoietic and Lymphatic System Neoplasm × merphos × Clear all

NCT06895473 2026-01-30

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Phase 2 Recruiting

Hematopoietic and Lymphatic System Neoplasm